Stock Events

Stock Events

Telo Genomics 

€0
0
+€0+0% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 3D0A.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap19.48B
Illumina provides genomic sequencing and array-based technologies, directly competing in the genomics industry.
Pacific Biosciences of California
PACB
Mkt Cap404.68M
Pacific Biosciences offers long-read sequencing technologies, which compete with Telo Genomics' molecular technology in genome analysis.
Qiagen NV
QGEN
Mkt Cap8.46B
Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, overlapping with Telo Genomics' market.
Guardant Health
GH
Mkt Cap12.31B
Guardant Health specializes in blood-based cancer diagnostics, competing in the genomic diagnostics space.
Fulgent Genetics
FLGT
Mkt Cap525.3M
Fulgent Genetics offers comprehensive genetic testing, directly competing in the genomic and molecular diagnostics industry.
Bionano Genomics
BNGO
Mkt Cap13.31M
Bionano Genomics provides tools for genomic analysis, competing in the same technology space as Telo Genomics.
Twist Bioscience
TWST
Mkt Cap3.08B
Twist Bioscience operates in the synthetic biology and genomics field, offering products that compete with genomic analysis technologies.
EXACT Sciences
EXAS
Mkt Cap20.03B
Exact Sciences is known for its non-invasive cancer screening products, competing in the genomic diagnostics market.
Intellia Therapeutics
NTLA
Mkt Cap1.55B
Intellia Therapeutics is involved in CRISPR technology for genome editing, competing indirectly by offering alternative approaches to genomic understanding and treatments.

About

Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. It provides telomere analysis platform with diagnostic and prognostic applications; and solutions with liquid biopsies and related technologies in oncology and neurological diseases. The company's lead application is Telo-MM, a solution that provides actionable information to medical professionals in the treatment of Multiple Myeloma, a form of blood cancer. Its solutions also include TeloView, a proprietary software platform used to quantify specific features of each patient's telomeres. The company serves pathologists, clinicians, academic researchers, and drug developers. Telo Genomics Corp. has a collaboration agreement with the Mayo Clinic to validate its Telo-MM tests for multiple myeloma. The company was formerly known as 3D Signatures Inc. and changed its name to Telo Genomics Corp. in April 2019. Telo Genomics Corp. was incorporated in 2014 and is headquartered in Toronto, Canada.
Show more...
CEO
Dr. Hans Knecht M.D.
Employees
8
Country
United States
ISIN
CA87975M2085

Listings

STU
DE
3D0A.STU
MU
DE
3D0A.MU
V
CA
TELO.V
OTC Link
US
TDSGF

0 Comments

Share your thoughts

FAQ

What is Telo Genomics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Telo Genomics stocks are traded under the ticker 3D0A.MU.
How many employees does Telo Genomics have?▼
As of April 12, 2026, the company has 8 employees.
In which sector is Telo Genomics located?▼
Telo Genomics operates in the Health & Wellness sector.
When did Telo Genomics complete a stock split?▼
Telo Genomics has not had any recent stock splits.
Where is Telo Genomics headquartered?▼
Telo Genomics is headquartered in Toronto, United States.